(Shanghai, China), for lipidomics analysis
Limited time: $96 off first month FDA-approved As low as $25 per month *This estimate derives from Novo Nordisk's Phase 3 clinical trial results which showed 14.9% average weight loss over 68 weeks among people utilized a maximum tolerated dose of 2.4 mg of semaglutide once-weekly
During an in-office or telehealth appointment, patients can discuss their weight-loss goals, BMI, medical history, insurance benefits, self-pay options, and whether Mounjaro (tirzepatide) treatment may be appropriate for their individual needs
While allergic reactions can occur at any time during treatment, they often develop after prior sensitisation, so vigilance should be maintained even after multiple uneventful doses
However, the risks for human patients developing thyroid C-cell tumors have not yet been determined